MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2337/db07-1059

Медицинская библиотека · Diabetes · 2007

Multiple superoxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Genetics study.

Al-Kateb Hussam, Boright Andrew P, Mirea Lucia, Xie Xinlei, Sutradhar Rinku, Mowjoodi Alireza, Bharaj Bhupinder, Liu Michelle, Bucksa Jean M, Arends Valerie L, Steffes Michael W, Cleary Patricia A, Sun Wanjie, Lachin John M, Thorner Paul S, Ho Michael, McKnight Amy Jayne, Maxwell A Peter, Savage David A, Kidd Kenneth K, Kidd Judith R, Speed William C, Orchard Trevor J, Miller Rachel G, Sun Lei, Bull Shelley B, Paterson Andrew D, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group

СтатьяМногоцентровое исследованиеРандомизированное исследованиеПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПоддержка службы здравоохранения СШАПеревод в очереди

Аннотация

BACKGROUND

Despite familial clustering of nephropathy and retinopathy severity in type 1 diabetes, few gene variants have been consistently associated with these outcomes.

RESEARCH DESIGN AND

METHODS

We performed an individual-based genetic association study with time to renal and retinal outcomes in 1,362 white probands with type 1 diabetes from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. Specifically, we genotyped 1,411 SNPs that capture common variations in 212 candidate genes for long-term complications and analyzed them for association with the time from DCCT baseline to event for renal and retinal outcomes using multivariate Cox proportion hazards models. To address multiple testing and assist interpretation of the results, false discovery rate q values were calculated separately for each outcome.

RESULTS

We observed association between rs17880135 in the 3' region of superoxide dismutase 1 (SOD1) and the incidence of both severe nephropathy (hazard ratio [HR] 2.62 [95% CI 1.64-4.18], P = 5.6 x 10(-5), q = 0.06) and persistent microalbuminuria (1.82 [1.29-2.57], P = 6.4 x 10(-4), q = 0.46). Sequencing and fine-mapping identified additional SOD1 variants, including rs202446, rs9974610, and rs204732, which were also associated (P < 10(-3)) with persistent microalbuminuria, whereas rs17880135 and rs17881180 were similarly associated with the development of severe nephropathy. Attempts to replicate the findings in three cross-sectional case-control studies produced equivocal results. We observed no striking differences between risk genotypes in serum SOD activity, serum SOD1 mass, or SOD1 mRNA expression in lymphoblastoid cell lines.

CONCLUSIONS

Multiple variations in SOD1 are significantly associated with persistent microalbuminuria and severe nephropathy in the DCCT/EDIC study.

Для цитирования: Al-Kateb Hussam, Boright Andrew P, Mirea Lucia, Xie Xinlei, Sutradhar Rinku, Mowjoodi Alireza, Bharaj Bhupinder, Liu Michelle, Bucksa Jean M, Arends Valerie L, Steffes Michael W, Cleary Patricia A, Sun Wanjie, Lachin John M, Thorner Paul S, Ho Michael, McKnight Amy Jayne, Maxwell A Peter, Savage David A, Kidd Kenneth K, Kidd Judith R, Speed William C, Orchard Trevor J, Miller Rachel G, Sun Lei, Bull Shelley B, Paterson Andrew D, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Multiple superoxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Genetics study.. Diabetes. 2007. DOI: 10.2337/db07-1059.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.